Department of Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, China.
Department of Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, China; Department of Radiology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China.
Acad Radiol. 2024 Dec;31(12):4934-4945. doi: 10.1016/j.acra.2024.06.002. Epub 2024 Jun 19.
It is critical to predict early recurrence (ER) after percutaneous thermal ablation (PTA) for hepatocellular carcinoma (HCC). We aimed to develop and validate a delta-radiomics nomogram based on multi-phase contrast-enhanced magnetic resonance imaging (MRI) to preoperatively predict ER of HCC after PTA.
We retrospectively enrolled 164 patients with HCC and divided them into training, temporal validation, and other-scanner validation cohorts (n = 110, 29, and 25, respectively). The volumes of interest of the intratumoral and/or peritumoral regions were delineated on preoperative multi-phase MR images. Original radiomics features were extracted from each phase, and delta-radiomics features were calculated. Logistic regression was used to train the corresponding radiomics models. The clinical and radiological characteristics were evaluated and combined to establish a clinical-radiological model. A fusion model comprising the best radiomics scores and clinical-radiological risk factors was constructed and presented as a nomogram. The performance of each model was evaluated and recurrence-free survival (RFS) was assessed.
Child-Pugh grade B, high-risk tumor location, and an incomplete/absent tumor capsule were independent predictors of ER. The optimal radiomics model comprised 12 delta-radiomics features with areas under the curve (AUCs) of 0.834, 0.795, and 0.769 in the training, temporal validation, and other-scanner validation cohorts, respectively. The nomogram showed the best predictive performance with AUCs as 0.893, 0.854, and 0.827 in the three datasets. There was a statistically significant difference in RFS between the risk groups calculated using the delta-radiomics model and nomogram.
The nomogram combined with the delta-radiomic score and clinical-radiological risk factors could non-invasively predict ER of HCC after PTA.
预测经皮热消融(PTA)治疗肝细胞癌(HCC)后的早期复发(ER)至关重要。我们旨在开发和验证一种基于多期对比增强磁共振成像(MRI)的 delta 放射组学列线图,以术前预测 HCC 经 PTA 治疗后的 ER。
我们回顾性纳入了 164 例 HCC 患者,并将其分为训练、时间验证和其他扫描仪验证队列(n=110、29 和 25)。在术前多期 MRI 图像上勾画肿瘤内和/或肿瘤周围感兴趣区域的容积。从每个相位提取原始放射组学特征,并计算 delta 放射组学特征。使用逻辑回归训练相应的放射组学模型。评估临床和影像学特征,并将其组合以建立临床-放射学模型。构建包含最佳放射组学评分和临床-放射学危险因素的融合模型,并以列线图表示。评估每个模型的性能,并评估无复发生存(RFS)。
Child-Pugh 分级 B、高危肿瘤位置和不完全/无肿瘤包膜是 ER 的独立预测因子。最佳放射组学模型包含 12 个 delta 放射组学特征,在训练、时间验证和其他扫描仪验证队列中的 AUC 分别为 0.834、0.795 和 0.769。列线图在三个数据集的 AUC 分别为 0.893、0.854 和 0.827,具有最佳的预测性能。使用 delta 放射组学模型和列线图计算的风险组之间的 RFS 存在统计学差异。
该列线图结合 delta 放射组学评分和临床-放射学危险因素可无创预测 HCC 经 PTA 治疗后的 ER。